

Cover Story
By Paul Goldberg and Jacquelyn Cobb
How is the enterprise of cancer research doing after the first 100 days of the Trump administration?
Cancer Policy
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for May 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Science advocates organize march in DC to demand impeachment of RFK Jr.
- Friends study points to ctDNA’s potential to serve as an intermediate endpoint in NSCLC
ctMoniTR project aims to improve efficiency in development of intermediate endpoints - Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA



















